Compare EVAX & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVAX | NFE |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5M | 24.6M |
| IPO Year | 2020 | 2018 |
| Metric | EVAX | NFE |
|---|---|---|
| Price | $2.81 | $4.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $11.25 | N/A |
| AVG Volume (30 Days) | 41.7K | ★ 626.3K |
| Earning Date | 11-19-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,504,037,000.00 |
| Revenue This Year | N/A | $108.26 |
| Revenue Next Year | N/A | $3.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.72 | $0.23 |
| 52 Week High | $8.10 | $16.90 |
| Indicator | EVAX | NFE |
|---|---|---|
| Relative Strength Index (RSI) | 40.02 | 44.17 |
| Support Level | N/A | $0.40 |
| Resistance Level | $3.62 | $7.13 |
| Average True Range (ATR) | 0.14 | 0.51 |
| MACD | -0.04 | -0.43 |
| Stochastic Oscillator | 28.57 | 12.01 |
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
New Fortress Energy Inc is an integrated gas-to-power company. It owns and operates natural gas and liquefied natural gas (LNG) infrastructure, and an integrated fleet of ships and logistics assets to deliver turnkey energy solutions to markets globally. The company's reportable segments are: Terminals and Infrastructure, and Ships. Maximum revenue is generated from the Terminals and Infrastructure segment, which includes vertically integrated gas-to-power solutions, spanning the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, facilities, and conversion or development of natural gas-fired power generation. Vessels that are utilized in the company's terminal, logistics, or sub-charter operations are included in this segment.